224 related articles for article (PubMed ID: 22159995)
21. The effect of the farnesyl protein transferase inhibitor SCH66336 on isoprenylation and signalling by the prostacyclin receptor.
O'Meara SJ; Kinsella BT
Biochem J; 2005 Feb; 386(Pt 1):177-89. PubMed ID: 15469414
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptor-β/δ, the acute signaling factor in prostacyclin-induced pulmonary vasodilation.
Li Y; Connolly M; Nagaraj C; Tang B; Bálint Z; Popper H; Smolle-Juettner FM; Lindenmann J; Kwapiszewska G; Aaronson PI; Wohlkoenig C; Leithner K; Olschewski H; Olschewski A
Am J Respir Cell Mol Biol; 2012 Mar; 46(3):372-9. PubMed ID: 22021335
[TBL] [Abstract][Full Text] [Related]
23. Participation of cAMP in a signal-transduction pathway relating erythrocyte deformation to ATP release.
Sprague RS; Ellsworth ML; Stephenson AH; Lonigro AJ
Am J Physiol Cell Physiol; 2001 Oct; 281(4):C1158-64. PubMed ID: 11546651
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of rat colon contractility by prostacyclin (IP-) receptor agonists: involvement of NANC neurotransmission.
Qian YM; Jones RL
Br J Pharmacol; 1995 May; 115(1):163-71. PubMed ID: 7544196
[TBL] [Abstract][Full Text] [Related]
25. Evidence for a second receptor for prostacyclin on human airway epithelial cells that mediates inhibition of CXCL9 and CXCL10 release.
Wilson SM; Sheddan NA; Newton R; Giembycz MA
Mol Pharmacol; 2011 Mar; 79(3):586-95. PubMed ID: 21173040
[TBL] [Abstract][Full Text] [Related]
26. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
[TBL] [Abstract][Full Text] [Related]
27. Divergent effects of low-O(2) tension and iloprost on ATP release from erythrocytes of humans with type 2 diabetes: implications for O(2) supply to skeletal muscle.
Sprague RS; Goldman D; Bowles EA; Achilleus D; Stephenson AH; Ellis CG; Ellsworth ML
Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H566-73. PubMed ID: 20511412
[TBL] [Abstract][Full Text] [Related]
28. Possible roles for ATP release from RBCs exclude the cAMP-mediated Panx1 pathway.
Keller AS; Diederich L; Panknin C; DeLalio LJ; Drake JC; Sherman R; Jackson EK; Yan Z; Kelm M; Cortese-Krott MM; Isakson BE
Am J Physiol Cell Physiol; 2017 Dec; 313(6):C593-C603. PubMed ID: 28855161
[TBL] [Abstract][Full Text] [Related]
29. Heterotrimeric G protein Gi is involved in a signal transduction pathway for ATP release from erythrocytes.
Olearczyk JJ; Stephenson AH; Lonigro AJ; Sprague RS
Am J Physiol Heart Circ Physiol; 2004 Mar; 286(3):H940-5. PubMed ID: 14615280
[TBL] [Abstract][Full Text] [Related]
30. Insulin inhibits human erythrocyte cAMP accumulation and ATP release: role of phosphodiesterase 3 and phosphoinositide 3-kinase.
Hanson MS; Stephenson AH; Bowles EA; Sprague RS
Exp Biol Med (Maywood); 2010 Feb; 235(2):256-62. PubMed ID: 20404042
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of ATP release from erythrocytes: a role for EPACs and PKC.
Adderley SP; Sridharan M; Bowles EA; Stephenson AH; Sprague RS; Ellsworth ML
Microcirculation; 2011 Feb; 18(2):128-35. PubMed ID: 21166931
[TBL] [Abstract][Full Text] [Related]
32. A comparative study of PGI2 mimetics used clinically on the vasorelaxation of human pulmonary arteries and veins, role of the DP-receptor.
Benyahia C; Boukais K; Gomez I; Silverstein A; Clapp L; Fabre A; Danel C; Leséche G; Longrois D; Norel X
Prostaglandins Other Lipid Mediat; 2013 Dec; 107():48-55. PubMed ID: 23850788
[TBL] [Abstract][Full Text] [Related]
33. Internalization and sequestration of the human prostacyclin receptor.
Smyth EM; Austin SC; Reilly MP; FitzGerald GA
J Biol Chem; 2000 Oct; 275(41):32037-45. PubMed ID: 10889200
[TBL] [Abstract][Full Text] [Related]
34. Smooth muscle proliferation and role of the prostacyclin (IP) receptor in idiopathic pulmonary arterial hypertension.
Falcetti E; Hall SM; Phillips PG; Patel J; Morrell NW; Haworth SG; Clapp LH
Am J Respir Crit Care Med; 2010 Nov; 182(9):1161-70. PubMed ID: 20622039
[TBL] [Abstract][Full Text] [Related]
35. Homeostasis of extracellular ATP in human erythrocytes.
Montalbetti N; Leal Denis MF; Pignataro OP; Kobatake E; Lazarowski ER; Schwarzbaum PJ
J Biol Chem; 2011 Nov; 286(44):38397-38407. PubMed ID: 21921036
[TBL] [Abstract][Full Text] [Related]
36. Factors affecting prostacyclin receptor agonist efficacy in different cell types.
Kam Y; Chow KB; Wise H
Cell Signal; 2001 Nov; 13(11):841-7. PubMed ID: 11583920
[TBL] [Abstract][Full Text] [Related]
37. Beta-adrenergic agonists regulate cell membrane fluctuations of human erythrocytes.
Tuvia S; Moses A; Gulayev N; Levin S; Korenstein R
J Physiol; 1999 May; 516 ( Pt 3)(Pt 3):781-92. PubMed ID: 10200425
[TBL] [Abstract][Full Text] [Related]
38. Prostacyclin-induced rundown of N-methyl-D-aspartate receptor currents in HEK293 cells is protein kinase A-dependent and NR2 subunit-selective.
Woodward JJ
J Neurochem; 2002 Feb; 80(4):598-604. PubMed ID: 11841567
[TBL] [Abstract][Full Text] [Related]
39. Acetylcholine-induced ex vivo ATP release from the human nasal mucosa.
Koizumi H; Ikezaki S; Ohbuchi T; Do BH; Hohchi N; Kawaguchi R; Kitamura T; Suzuki H
Auris Nasus Larynx; 2017 Aug; 44(4):422-427. PubMed ID: 27692399
[TBL] [Abstract][Full Text] [Related]
40. Prostaglandin I(2) analogues enhance growth-related oncogene-alpha expression in human monocyte-derived dendritic cells.
Kuo CH; Jan RL; Chu YT; Wang WL; Huang MY; Huang CH; Chen TH; Hung CH
Inflammation; 2010 Oct; 33(5):334-43. PubMed ID: 20195728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
